Navigation Links
BioCryst Receives Peramivir Request for Proposal From the U.S. Government
Date:9/21/2009

BIRMINGHAM, Ala., Sept. 21 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).

The RFP indicates that the minimum and maximum order quantities to be ordered by the government are 1,000 and 40,000 courses of anti-viral treatment. The RFP specifies that BioCryst would also be required to maintain the ability to manufacture additional treatment courses dependent on the volume and size of anti-viral orders received from HHS for additional needs for either treatment or prophylaxis. The current RFP process may or may not result in a government order for peramivir and does not guarantee issuance of an EUA.

BioCryst management is preparing a response to the RFP and intends to provide an update once the process has reached a conclusion.

About peramivir

Peramivir is an anti-viral agent that was discovered by BioCryst which inhibits the interactions of influenza neuraminidase, an enzyme which is critical to the spread of influenza within a host. In laboratory tests, peramivir has shown activity against pandemic H1N1 swine flu origin viral strains. Peramivir has been studied in patients with complicated and uncomplicated influenza. BioCryst's partner, Shionogi & Co., Ltd. is currently preparing to file for regulatory approval in Japan this year.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious disease
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
2. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
3. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
4. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
6. BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
7. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
8. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
9. BioCryst Executives to Present at Two Investor Conferences
10. BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
11. BioCryst to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 18, 2013 In a May 14, ... Double Mastectomy After Discovering Cancer Gene,” Fox News reported ... upon learning that she carried a gene that doctors ... cancer and a 50 percent risk of ovarian cancer ... on May 16, 2013 with a blog post entitled ...
(Date:5/18/2013)... (May 18, 2013) A ground-breaking advance in ... according to research presented today at Digestive Disease ... minimal withdrawal time for colonoscopies and exploring safer ... colonoscopy, doctors use a device called a colonoscope ... colorectal cancer allows a doctor to look for ...
(Date:5/18/2013)... York, New York (PRWEB) May 18, 2013 ... Gynecare pelvic mesh products continue to move forward in ... Superior Court, Bernstein Liebhard LLP reports. According to a ... Conference in the Ethicon pelvic mesh litigation will be ... that 2,755 complaints have been filed in the proceeding ...
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- It ... but new research shows that college women are more likely ... than are college men. Much of this difference ... on a weekly basis is much lower for women than ... for men. But, there,s good reason for that difference. Women ...
(Date:5/18/2013)... May 18, 2013 After working diligently for ... SizeItUp formally announced the integration of the fitment specs ... Genesis is set to stun the automobile market with its ... Hyundai Genesis is marked as the latest entry in the ... vehicles lined up for the year 2013. , Aptly ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2
... that reducing the levels of vascular endothelial growth factor (VEGF), ... vessel growth, in adult mice causes the death of photoreceptors ... essential to visual function. This finding, published in the November ... chronic use of promising new anti-VEGF drugs such as Lucentis, ...
... Commits to Multi-Million-Dollar Five-Year Program; Inaugural ... the Cure Global Promise Fund(R), LONDON, Nov. ... the,largest breast cancer advocacy organization in the world, ... supporter of breast cancer,charities in Europe, in a ...
... investigators to submit abstracts to present their research ... event dedicated to molecular imaging and nuclear medicineJune ... field of molecular imaging is vital and state-of-the-art," ... represents the society,s more than 17,000 molecular imaging ...
... voters with disabilities expected to vote in,presidential election, ... expected to vote in record numbers on Election ... Disabilities (AAPD), the largest,cross-disability membership organization in the ... are expected to cast their,ballots in the general ...
... osteoporosis management is a crucial element in hip,fracture ... patients who,suffer a hip fracture are referred to ... according to a study published in the,November 2008 ... Surgery,( http://www.ejbjs.org ), an osteoporosis management program ...
... LOS ANGELES, Nov. 3 World Champion athlete ... her debut as a member of the,California Governor,s ... included speaking to the student body of NEW ... active and healthy lifestyles., (Photo: http://www.newscom.com/cgi-bin/prnh/20081103/AQM074 ...
Cached Medicine News:Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 2Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 3Health News:SNM to showcase the latest research in molecular imaging and nuclear medicine 2Health News:Record Number of Voters with Disabilities Will Head to Polls 2Health News:Treating Osteoporosis After Hip Fracture 2Health News:Treating Osteoporosis After Hip Fracture 3Health News:Laila Ali Debuts as Member of California Governor's Council on Physical Fitness and Sports 2
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 /PRNewswire/ ... ABBV ) announced today an extension of their ... will fund and complete a Phase 2 program in ... into Phase 3.  Upon successful completion of the study, ... million.  The terms of the collaboration extension are in ...
(Date:5/16/2013)... 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ) ... , is scheduled to present at the upcoming 2013 ... at the Sheraton New York Hotel on Tuesday, May ... presentation will be accessible via a Webcast through a link ... Nektar website: http://www.nektar.com . This Webcast will be available ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...
... two-component fibrin sealant vapor heated ... commercially available fibrin sealant in ... are used for two specific ... to seal tissue. Both of ...
... With Plasmaseal's Proteus device the two ... blood is injected into Proteus' single use ... action base unit. The operator touches a ... plasma is separated by centrifugation. Then the ...
Medicine Products: